| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 |
| filingDate |
2004-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3186a0116767428de34d47cd5ec88d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c13d95fa81024e214d063112b1ed3c32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d2328e880262495cdf7070bec8bcf19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5da64e500b7371a574d897d938309e1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99e3727dbd4573d5f0c68f876f4f97a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68e2288589aac1d9eded92fc4fc8cee7 |
| publicationDate |
2012-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1606264-B1 |
| titleOfInvention |
Monocyclic anilide spirohydantoin cgrp receptor antagonists |
| abstract |
The present invention is directed to compounds that are antagonists of CGRP receptors and that are useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved. |
| priorityDate |
2003-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |